Details of the Drug

General Information of Drug (ID: DMIE9BG)

• Drug Name: 5-Methyl-2-p-tolyl-thiazol-4-ol
• Synonyms: CHEMBL69094; 5-Methyl-2-p-tolyl-thiazol-4-ol; 4-Thiazolol, 5-methyl-2-(4-methylphenyl)-; SCHEMBL9629237; BDBM50012393; 131786-76-0

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

• Drug Type: Small molecular drug
• #Ro5 Violations (Lipinski): 0:
  Molecular Weight (mw); 205.28
  Logarithm of the Partition Coefficient (xlogp); 3.4
  Rotatable Bond Count (rotbonds); 1
  Hydrogen Bond Donor Count (hbonddonor); 1
  Hydrogen Bond Acceptor Count (hbondacc); 3
• Chemical Identifiers:
  Formula: C11H11NOS
  IUPAC Name: 5-methyl-2-(4-methylphenyl)-1,3-thiazol-4-ol
  Canonical SMILES: CC1=CC=C(C=C1)C2=NC(=C(S2)C)O
  InChI: InChI=1S/C11H11NOS/c1-7-3-5-9(6-4-7)11-12-10(13)8(2)14-11/h3-6,13H,1-2H3
  InChIKey: CKXYNXQZWQQOOO-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 15691812
  TTD ID: D04IFV

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Arachidonate 5-lipoxygenase (5-LOX)	TT2J34L	LOX5_HUMAN	Inhibitor	[1]

Molecular Expression Atlas of This Drug

• The Studied Disease: Discovery agent
• ICD Disease Classification: N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Arachidonate 5-lipoxygenase (5-LOX)	DTT	ALOX5	4.15E-01	-0.06	-0.15

References

• [1] 4-hydroxythiazole inhibitors of 5-lipoxygenase. J Med Chem. 1991 Jul;34(7):2158-65.